• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CT 扫描与胸腔积液细胞学检查联合用于恶性胸腔积液的诊断。一项初步的病例对照研究。

Diagnosis of Malignant Pleural Effusion Using CT Scan and Pleural-Fluid Cytology Together. A Preliminary Case-Control Study.

机构信息

General Surgery, S. Maria degli Angeli Hospital, Pordenone, Italy

University of Padua, School of Medicine, Padua, Italy.

出版信息

Anticancer Res. 2020 Feb;40(2):1135-1139. doi: 10.21873/anticanres.14054.

DOI:10.21873/anticanres.14054
PMID:32014965
Abstract

BACKGROUND/AIM: The purposes of this study were to evaluate the usefulness of chest computed tomographic (CT) scan plus pleural fluid cytology (PFC) together in patients with malignant pleural effusion (PE), and to compare the results of these diagnostic tools in patients with malignant PE due to non-small-cell lung cancer and pulmonary metastases from other malignancies.

PATIENTS AND METHODS

The medical records of 185 patients with PE, who underwent chest CT, PFC and video-assisted thoracoscopy (VATS) thoracentesis followed by VATS-guided biopsy for diagnostic purpose, were reviewed. At the final diagnosis, 123 (66.5%) patients had malignant PE (cases), and 62 (33.5%) had benign PE (controls).

RESULTS

Overall, the sensitivity, specificity, and accuracy of CT and PFC were 65.0% vs. 67.5% 98.4% vs. 98.4%, and 76.2% vs. 77.8%, respectively. The combination of CT plus PFC significantly improved sensitivity (86.2%, p=0.003) and accuracy (90.8%, p=0.02).

CONCLUSION

CT and PFC used together may lead to approximately 100% specificity and >90% sensitivity in distinguishing between benign and malignant PE.

摘要

背景/目的:本研究旨在评估胸部计算机断层扫描(CT)加胸腔积液细胞学(PFC)联合用于恶性胸腔积液(PE)患者的效用,并比较这些诊断工具在非小细胞肺癌和其他恶性肿瘤肺转移引起的恶性 PE 患者中的结果。

患者与方法

回顾了 185 例 PE 患者的病历,这些患者接受了胸部 CT、PFC 和视频辅助胸腔穿刺术(VATS)胸腔穿刺术,随后进行了 VATS 引导下活检以进行诊断。最终诊断为 123 例(66.5%)恶性 PE(病例)和 62 例(33.5%)良性 PE(对照)。

结果

总体而言,CT 和 PFC 的敏感性、特异性和准确性分别为 65.0% vs. 67.5%、98.4% vs. 98.4%和 76.2% vs. 77.8%。CT 加 PFC 的联合显著提高了敏感性(86.2%,p=0.003)和准确性(90.8%,p=0.02)。

结论

CT 和 PFC 联合使用可在鉴别良性和恶性 PE 时实现接近 100%的特异性和>90%的敏感性。

相似文献

1
Diagnosis of Malignant Pleural Effusion Using CT Scan and Pleural-Fluid Cytology Together. A Preliminary Case-Control Study.CT 扫描与胸腔积液细胞学检查联合用于恶性胸腔积液的诊断。一项初步的病例对照研究。
Anticancer Res. 2020 Feb;40(2):1135-1139. doi: 10.21873/anticanres.14054.
2
Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.胸腔积液细胞学、癌胚抗原和 C 反应蛋白联合检测对肺转移合并恶性胸腔积液患者的诊断准确性。
Anticancer Res. 2020 Oct;40(10):5877-5881. doi: 10.21873/anticanres.14607.
3
[Thoracocentesis for the assessment of lung cancer with pleural effusion].[胸腔穿刺术用于评估伴有胸腔积液的肺癌]
Arch Bronconeumol. 2002 Oct;38(10):479-84. doi: 10.1016/s0300-2896(02)75269-1.
4
Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.内科胸腔镜与 CT 引导下 Abrams 胸膜活检针用于胸腔积液患者诊断的比较:一项随机对照试验。
Chest. 2010 Jun;137(6):1362-8. doi: 10.1378/chest.09-0884. Epub 2010 Feb 12.
5
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.利用一组肿瘤标志物(癌胚抗原、癌抗原125、糖类抗原15-3和细胞角蛋白19片段)检测胸腔积液以鉴别诊断良性和恶性胸腔积液。
Chest. 2004 Dec;126(6):1757-63. doi: 10.1378/chest.126.6.1757.
6
Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion?微卫星改变与游离细胞 DNA 分析:能否提高恶性胸腔积液细胞学诊断的灵敏度?
Rejuvenation Res. 2012 Jun;15(3):265-73. doi: 10.1089/rej.2011.1260. Epub 2012 May 2.
7
Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.双能谱 CT 鉴别良恶性胸腔积液。
PLoS One. 2018 Apr 11;13(4):e0193714. doi: 10.1371/journal.pone.0193714. eCollection 2018.
8
Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.上皮样恶性胸膜间皮瘤患者的胸腔液细胞学检出率和内脏胸膜侵犯。
J Thorac Oncol. 2012 Mar;7(3):595-8. doi: 10.1097/JTO.0b013e31823e0667.
9
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.标准胸膜活检与CT引导下切割针活检对胸腔积液中恶性疾病的诊断:一项随机对照试验
Lancet. 2003 Apr 19;361(9366):1326-30. doi: 10.1016/s0140-6736(03)13079-6.
10
Diagnostic yield of closed pleural brushing.闭式胸膜刷检的诊断阳性率
Tuberk Toraks. 2005;53(3):238-44.

引用本文的文献

1
The value of computed tomography-based radiomics for predicting malignant pleural effusions.基于计算机断层扫描的影像组学在预测恶性胸腔积液中的价值。
Front Oncol. 2024 Aug 12;14:1419343. doi: 10.3389/fonc.2024.1419343. eCollection 2024.
2
Differentiating malignant and benign pleural effusion in patients with lung cancer: an F-FDG PET/CT retrospectively study.肺癌患者恶性与良性胸腔积液的鉴别:一项F-FDG PET/CT回顾性研究。
Front Oncol. 2023 Jun 30;13:1192870. doi: 10.3389/fonc.2023.1192870. eCollection 2023.
3
Characteristics of pleural effusion with a high adenosine deaminase level: a case-control study.
胸腔积液腺苷脱氨酶水平升高的特征:病例对照研究。
BMC Pulm Med. 2022 Sep 21;22(1):359. doi: 10.1186/s12890-022-02150-4.
4
The clinical efficacy of traditional Chinese medicine in the treatment of malignant pleural effusion: A protocol of systematic review and meta-analysis.中药治疗恶性胸腔积液的临床疗效:一项系统评价与Meta分析方案
Medicine (Baltimore). 2020 Sep 25;99(39):e22403. doi: 10.1097/MD.0000000000022403.